Market snapshot
TJX Companies Inc shares settled at $131.31 on Sep. 2 and were quoted at $131.73 in premarket trading on Sep. 3, 2026, at 7:55 AM EDT. The company’s 52-week trading range stands at $131.18 to $170.00. Market capitalization was $144.44 billion as of Sep. 3, 2026. Short-term performance has weakened sharply, with a one-month return of -16.63% and a year-to-date return of -14.32%.
Why the low is more than a headline
The recent drop is tied to an operational setback rather than being solely market noise. Marmaxx, a core division, recorded a slowdown in comparable-store sales to 1% from a prior 6% pace. That division is material to the company’s financials, accounting for over 60% of total sales and nearly 70% of EBIT, according to reporting from Jefferies. The magnitude of Marmaxx’s contribution makes its slowdown a central factor in the stock’s re-pricing.
Technical landscape
Technical indicators are signalling distress across timeframes. Both daily and weekly readings are categorized as Strong Sell. The daily relative strength index stood at 19.326, while the weekly RSI was 32.888 in the latest technical snapshot. An RSI below 30 typically indicates oversold conditions, which can prompt short-term bounces even when the broader downtrend remains intact.
At the same time, directional strength is pronounced: the daily Average Directional Index is 66.586, a level that denotes a powerful trend. Price sits below the daily 5-day and 10-day moving averages, while weekly moving averages remain substantially higher. In short, oversold momentum is present but is contending with persistent selling pressure.
Longer-term fundamentals
Despite the near-term selling, core business metrics show improvement over multiple years. Revenue rose from $48.55 billion in fiscal 2022 to $60.37 billion in fiscal 2026. Over the same span net margin expanded from 6.8% to 9.1%. Consensus estimates still point to earnings growth, with fiscal 2027 EPS forecast at $5.28 compared with $4.73 reported in fiscal 2026.
Nevertheless, valuation metrics do not reflect a distressed multiple. The forward price-to-earnings ratio was 24.8 times as of Jan. 31, 2027, indicating that the market is still pricing the business at a premium despite the recent drawdown.
Analyst views and valuation dispersion
Analyst recommendations and price targets show a wide range of outcomes. Jefferies has a Hold rating with a $145 target, highlighting execution risk in Marmaxx (Aug. 26, 2026). Bernstein is on the opposite end with an Outperform stance and a $175 target, anticipating execution improvements (Aug. 24, 2026). Wells Fargo sits between those views with an Equal Weight rating and a $140 target; Wells Fargo reported a fair value of $132.40 (Aug. 19, 2026).
Separately, a calculated fair value of $129.70 implies about 1.2% downside from the recent premarket quote, suggesting limited immediate margin of safety at current prices.
What would change the setup?
The path toward a more compelling entry would require stabilization in Marmaxx comparable sales and a technical recovery in which price reclaims the weekly pivot near $137.05. Until those conditions are met, the combination of shallow valuation cushion, strong downtrend momentum, and the unresolved operating issue argues for restraint.
Conclusion
The underlying business shows durable improvement in revenue and margins, and the company continues to carry expectations for EPS growth into fiscal 2027. That constitutes the enduring bull case: sustained top-line growth, expanding margins, and ongoing store growth over the long term. The bear case centers on a potential persistent execution gap at Marmaxx that competitors could exploit, while investors continue to pay a premium multiple.
Given the current evidence - technical momentum in favor of sellers, limited downside cushion versus fair value, and a clear operating headwind - the immediate setup favors patience rather than an aggressive buy at the new 52-week low.